Clinical trials
Disease trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 11 |
| 2025 | 11 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 25 |
| Recruiting | 17 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital of Xiamen University | 8 |
| Peking University First Hospital | 5 |
| Zhejiang University | 4 |
| Sun Yat-sen University | 3 |
| Xijing Hospital | 3 |
| Affiliated Hospital to Academy of Military Medical Sciences | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Peking Union Medical College Hospital | 2 |
| Peking University | 2 |
| Shanghai Chest Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Disease | 78 |
| Lung Neoplasms | 11 |
| Prostatic Neoplasms | 9 |
| Neoplasms | 8 |
| Stomach Neoplasms | 6 |
| Esophageal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Hypoxia | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.